Project Panacea: Where Synthetic Bio Meets Real-World Impact
- Aug 4, 2025
- 1 min read
A non-invasive breast cancer therapy?
Yes, and it’s closer than you think.
Project Panacea is the bold new collaboration between TheraSyn Bio and Rubix LS, combining synthetic biology + real-world data to take on one of oncology’s biggest challenges and actually make it equitable.
What’s inside the case study:
A topical therapy rooted in synthetic bio
Real-time simulation using digital twins
18M+ diverse patient datasets driving precision
Designed for historically excluded patients
What's next as clinical trials prepare to launch in 2026
Hear from Daisy Gallagher and Reginald Swift on how this collaboration is setting a new standard for oncology clinical trials.
Read the full case study here.
